Skip to main content
. 2016 May 26;6:26909. doi: 10.1038/srep26909

Figure 6. Niaspan treatment decreases VEGF and increases Ang-1 expression in the HREC compared to non-Niaspan treatment HREC.

Figure 6

(A) RT-PCR experiments to determine miR-126 expression in the HREC (n = 3/group). (B,C) Western blot and quantitative measurement for VEGF and Ang-1 expressions in the HREC (n = 4/group). *P < 0.05 compared with nondiabetic HREC (CON). #P < 0.05 compared with hyperglycemia treatment (DR). **P < 0.05 compared with the HREC without miR-126 inhibitor pretreatment.